![Maha Katabi](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Maha Katabi
Presidente presso
Exactis Innovation
Patrimonio netto: - $ in data 31/07/2026
Profilo
Maha Katabi is the founder of Oxalis Capital, Inc. Current roles include Chairman at Exactis Innovation since 2019, Director at BIOTECanada, Director at Quanta Therapeutics, Inc. since 2021, Director at Star OpCo, Inc. since 2023, Director at Marea Therapeutics, Inc., Director at Ascendis Pharma, Inc., General Partner at Sofinnova Investments, Inc. since 2020, and Partner at Sectoral Asset Management Inc (Private Equity) since 2008.
Former roles include Director at Caprion Pharmaceuticals, Inc., RainDance Technologies, Inc., Apellis Pharmaceuticals, Inc., MacroGenics, Inc., Resonant Medical, Inc., NeurAxon, Inc., eFFECTOR Therapeutics Operations, Inc., and Vera Therapeutics, Inc.; Non-Executive Director at F2G Ltd.; Director at Amplyx Pharmaceuticals, Inc. (2020–2021), NorthSea Therapeutics BV (2019–2021), Jade Biosciences, Inc. (2020–2024), Aiolos Bio, Inc. (2023–2024), Rayzebio, Inc. (2022–2024), and Gyroscope Therapeutics Holdings Plc (2021–2022); Board Member at Gyroscope Therapeutics Ltd. (2021–2022); Investment Manager at Sectoral Asset Management, Inc. (2008–2018); Vice President at Ventures West Management, Inc. (2004–2007); Associate at Transfer Technologies Commercialisation Capital; and Associate at T2C2 Capital (1999–2002).
Education includes a doctorate conferred in 1999 and an undergraduate degree conferred in 1994, both from McGill University.
Partecipazioni note in società pubbliche
| Società | Data | Numero di azioni | Valutazione | Data di valutazione |
|---|---|---|---|---|
| 24/03/2026 | 0 ( -.--% ) | - $ | 31/07/2026 |
Posizioni attive di Maha Katabi
| Società | Posizione | Inizio |
|---|---|---|
Sectoral Asset Management Inc (Private Equity)
 Sectoral Asset Management Inc (Private Equity) Investment ManagersFinance Sectoral Asset Management invests in companies located in North America and Europe. The firm focuses on biotechnology, medtech and life sciences sectors. It provides financing for late stage capital requirements. | Investitore di Private Equity | 01/01/2008 |
Sofinnova Investments, Inc.
 Sofinnova Investments, Inc. Investment ManagersFinance Sofinnova Investment invests in companies located in the United States and Europe. The firm targets companies operating in the fields of health technology services and life science. It participates in early and later stage capital requirements. | Investitore di Private Equity | 01/04/2019 |
Quanta Therapeutics, Inc.
 Quanta Therapeutics, Inc. BiotechnologyHealth Technology Develops allosteric inhibitors for RAS-driven cancers | Direttore/Membro del Consiglio | 01/06/2021 |
Exactis Innovation
 Exactis Innovation Miscellaneous Commercial ServicesCommercial Services Operates as a non profit clinical trials company | Presidente | 01/02/2019 |
BIOTECanada
 BIOTECanada BiotechnologyHealth Technology Engages in research and development in biotechnology | Direttore/Membro del Consiglio | - |
Ascendis Pharma, Inc.
 Ascendis Pharma, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops endocrinology, rare disease and oncology medicines & transient conjugation platform | Direttore/Membro del Consiglio | - |
Star Therapeutics, Inc.
 Star Therapeutics, Inc. BiotechnologyHealth Technology Develops antibody therapies for hematology and immunology problems | Direttore/Membro del Consiglio | 01/06/2023 |
Precedenti posizioni note di Maha Katabi
| Società | Posizione | Fine |
|---|---|---|
| JADE BIOSCIENCES, INC. | Direttore/Membro del Consiglio | 01/09/2024 |
| RAYZEBIO, INC. | Direttore/Membro del Consiglio | 26/02/2024 |
| ░░░░░░░░░ ░░░░░░░░░░░░ ░░░░░░░░ ░░░ | ░░░░░░░░░░░░░░░░ ░░░ ░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░░ ░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░░░ ░░░ ░░░░░░░░░ | ░░░░░░░░░░ |
Formazione di Maha Katabi
Esperienze
Posizioni ricoperte
Attive
Inattive
Società nel listino
Aziende private
Relazioni
96
Relazioni di 1° grado
28
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 28 |
|---|---|
Caprion Pharmaceuticals, Inc.
 Caprion Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Discovered and developed pharmaceutical products | Health Technology |
RainDance Technologies, Inc.
 RainDance Technologies, Inc. Medical SpecialtiesHealth Technology Develops and commercializes professional laboratory system | Health Technology |
Apellis Pharmaceuticals, Inc.
 Apellis Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops therapeutics and drug delivery technologies to address chronic inflammatory diseases | Health Technology |
Sofinnova Investments, Inc.
Sofinnova Investments, Inc. Investment ManagersFinance Sofinnova Investment invests in companies located in the United States and Europe. The firm targets companies operating in the fields of health technology services and life science. It participates in early and later stage capital requirements. | Finance |
Sectoral Asset Management, Inc.
 Sectoral Asset Management, Inc. Investment ManagersFinance Sectoral aims to achieve superior returns for their investors by concentrating on primary research of company fundamentals and in-depth due diligence on companies to assess their scientific, business, financial and ESG aspects. The firm offers four Healthcare strategies: Global Healthcare, Emerging Healthcare, Small & Mid-Cap Healthcare & Biotech. They employ a bottom-up investment approach that can be categorized as Growth at a Reasonable Price (GARP). | Finance |
MacroGenics, Inc.
 MacroGenics, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes antibody-based therapeutics for the treatment of cancer | Health Technology |
McGill University
 McGill University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Ventures West Management, Inc.
 Ventures West Management, Inc. Investment ManagersFinance Ventures West Management invests in early-stage technology companies across Canada. They focus on investments in biotechnology, clean technology and communications. Ventures West Management is an active value-added venture capital partner. The firm contributes resources to ensure that portfolio companies build value. Ventures West often has representation on the board of directors of their portfolio companies. The firm looks for companies with experienced management teams, competitive advantages and attractive markets. They target early-stage companies that are seeking seed or Series A funding. The firm also looks for companies with the potential for a profitable exit within 4 to 6 years | Finance |
Resonant Medical, Inc.
 Resonant Medical, Inc. Medical SpecialtiesHealth Technology Develops, manufactures and distributes 3D ultrasound image-guided adaptive radiotherapy products | Health Technology |
Transfer Technologies Commercialisation Capital
 Transfer Technologies Commercialisation Capital Investment ManagersFinance T²C² seeks to identify (in universities, research centers and industry) business opportunities and turn them into real businesses. They invest in health sciences, with an emphasis on biotechnology, pharmaceuticals and medical equipment. Criteria that are necessary for the selection of a project are: excellent quality of science and technology, complementarities and equilibrium of the team, intellectual property and market potential. | Finance |
F2G Ltd.
 F2G Ltd. Pharmaceuticals: MajorHealth Technology Engages in research and development of novel drugs for life-threatening systemic fungal diseases treatment | Health Technology |
NeurAxon, Inc.
 NeurAxon, Inc. Miscellaneous Commercial ServicesCommercial Services Researches and develops nervous system disorder therapies | Commercial Services |
BIOTECanada
BIOTECanada BiotechnologyHealth Technology Engages in research and development in biotechnology | Health Technology |
Amplyx Pharmaceuticals, Inc.
 Amplyx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and distributes medicines | Health Technology |
eFFECTOR Therapeutics Operations, Inc.
 eFFECTOR Therapeutics Operations, Inc. BiotechnologyHealth Technology Operates a clinical-stage biopharmaceutical company that develops oncology drugs | Health Technology |
Sectoral Asset Management Inc (Private Equity)
Sectoral Asset Management Inc (Private Equity) Investment ManagersFinance Sectoral Asset Management invests in companies located in North America and Europe. The firm focuses on biotechnology, medtech and life sciences sectors. It provides financing for late stage capital requirements. | Finance |
Ascendis Pharma, Inc.
Ascendis Pharma, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops endocrinology, rare disease and oncology medicines & transient conjugation platform | Health Technology |
NorthSea Therapeutics BV
 NorthSea Therapeutics BV BiotechnologyHealth Technology Operates as a clinical stage biotechnology company that develops novel strategies for the treatment of metabolic, inflammatory and fibrotic diseases | Health Technology |
Gyroscope Therapeutics Ltd.
 Gyroscope Therapeutics Ltd. BiotechnologyHealth Technology Develops gene therapies and medicines for eye diseases | Health Technology |
Exactis Innovation
Exactis Innovation Miscellaneous Commercial ServicesCommercial Services Operates as a non profit clinical trials company | Commercial Services |
Quanta Therapeutics, Inc.
Quanta Therapeutics, Inc. BiotechnologyHealth Technology Develops allosteric inhibitors for RAS-driven cancers | Health Technology |
Aerovate Therapeutics, Inc.
 Aerovate Therapeutics, Inc. BiotechnologyHealth Technology Provides gene therapy services | Health Technology |
Vera Therapeutics, Inc.
 Vera Therapeutics, Inc. BiotechnologyHealth Technology Operates as clinical-stage biotechnology company, which focuses on development and treatments for immunological & inflammatory diseases | Health Technology |
T2C2 Capital
 T2C2 Capital Financial ConglomeratesFinance Provides investment services | Finance |
Rayzebio, Inc.
 Rayzebio, Inc. Pharmaceuticals: MajorHealth Technology Develops radiopharmaceutical therapeutics for cancer treatment | Health Technology |
Gyroscope Therapeutics Holdings Plc
 Gyroscope Therapeutics Holdings Plc BiotechnologyHealth Technology Develops clinical-stage gene therapies to treat diseases of eyes | Health Technology |
Oxalis Capital, Inc.
 Oxalis Capital, Inc. Investment ManagersFinance Oxalis Capital invests in companies located in Canada. The firm targets companies operating in the field of biopharmaceutical sector. It provides financing for buyout capital requirements. | Finance |
Star Therapeutics, Inc.
Star Therapeutics, Inc. BiotechnologyHealth Technology Develops antibody therapies for hematology and immunology problems | Health Technology |
